首页> 外文期刊>Journal of affective disorders >Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion
【24h】

Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion

机译:阿托莫西汀,赖氨酸安非他明,安非他酮和哌醋甲酯治疗儿童和青少年注意缺陷多动障碍的比较疗效和可接受性:一项以安非他酮为重点的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: There is a lack of comparative effectiveness research among attention deficit hyperactivity disorder (ADHD) drugs in terms of efficacy and acceptability, where bupropion is compared with atomoxetine, lisdexamfetamine and methylphenidate. The main aim of this work was to compare the efficacy and acceptability of these drugs in children and adolescents using a metaanalysis.
机译:目的:关于注意力缺陷多动障碍(ADHD)药物在功效和可接受性方面缺乏比较功效研究,其中将安非他酮与阿莫西汀,赖斯氨苯丙胺和哌醋甲酯进行比较。这项工作的主要目的是使用荟萃分析比较这些药物在儿童和青少年中的功效和可接受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号